Casper Joseph Michael
SEC insider (Form 3/4/5 filer). CIK 0002106955. Chief Operating Officer at NRX Pharmaceuticals, Inc. (NRXP). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 27, 2026. Located in WILMINGTON, DE.
Companies Casper Joseph Michael has filed insider reports for
- NRX Pharmaceuticals, Inc. (NRXP): Officer, Chief Operating Officer
Casper Joseph Michael
CIK: 0002106955
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NRXP
NRX Pharmaceuticals, Inc.
Officer